AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...

AstraZeneca reported its largest quarterly revenue ever, as soaring sales of cancer drugs helped the drugmaker beat ...

AstraZeneca beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and ...

The pharmaceutical company posted a 14% on-year increase in third-quarter core earnings per share, while revenue rose to ...

COVID-19 vaccine would continue despite many European nations pausing vaccination to investigate serious side effects ...

AstraZeneca CEO Pascal Soriot discusses Q3 earnings and the pharma giant's relationship with the U.S. administration.

(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on ...

CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported third-quarter net income of $2.53 billion. On a per-share basis, the Cambridge, Britain-based company ...

AstraZeneca (AZN.L, AZN.ST) reiterated its full-year guidance on expectations, citing sustained growth momentum after ...

AstraZeneca reported stronger-than-expected third-quarter results on Thursday, driven by robust sales across its oncology, cardiovascular and renal portfolios. The company kept its full-year outlook ...

The latest investor updates on stocks that are trending on Thursday.

AstraZeneca PLC ADR closed 6.26% below its 52-week high of $86.57, which the company achieved on October 6th.